Finch Therapeutics Group Q1 EPS $(0.52) Up From $(1.00) YoY, Sales $354.00K Down From $3.55M YoY
Finch Therapeutics Group Q1 EPS $(0.52) Up From $(1.00) YoY, Sales $354.00K Down From $3.55M YoY
Finch Therapeutics Group (NASDAQ:FNCH) reported quarterly losses of $(0.52) per share. This is a 48 percent increase over losses of $(1.00) per share from the same period last year. The company reported $354.00 thousand in sales this quarter. This is a 90.04 percent decrease over sales of $3.55 million the same period last year.
Finch Therapeutics Group (NASDAQ:FNCH) reported quarterly losses of $(0.52) per share. This is a 48 percent increase over losses of $(1.00) per share from the same period last year. The company reported $354.00 thousand in sales this quarter. This is a 90.04 percent decrease over sales of $3.55 million the same period last year.
芬奇治療集團(納斯達克代碼：FNCH)公佈季度虧損為每股0.52美元。這比去年同期每股虧損1.00美元增加了48%。該公司報告本季度銷售額為35.4萬美元。這比去年同期355萬美元的銷售額下降了90.04%。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧